NEOGENOMICS, INC. (NEO) Operating margin 2016–2025
NEOGENOMICS, INC. (NEO) operating margin by fiscal year — reported operating income divided by reported revenue.
-15.9%FY2025 · since FY2016: 0.9% → -15.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -15.9% | -2.0 pp |
| FY2024 | -13.9% | +4.3 pp |
| FY2023 | -18.2% | +12.7 pp |
| FY2022 | -30.9% | -6.4 pp |
| FY2021 | -24.5% | -21.4 pp |
| FY2020 | -3.1% | -6.3 pp |
| FY2019 | 3.2% | -0.4 pp |
| FY2018 | 3.6% | +2.4 pp |
| FY2017 | 1.2% | +0.3 pp |
| FY2016 | 0.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice